Speak with a Defective Drug Specialist
Get answers to legal & medical questions
patient advocate


Latest News

Date posted: 1/30/2014

For over a year, thousands of lawsuits have been working their way through a special federal court for victims who suffered bleeding while taking the atrila fibrillation drug Pradaxa.
Now, it looks as though families who are dealing with the injury or death of a loved one are one step closer to getting justice.
Last week, U.S. District Judge David Herndon, who currently oversees more than 2,000 Pradaxa lawsuits, selected four Bellwether cases and set the first trail to begin on August 11, 2014.
This will restrict attempts by manufacturer Boehringer Ingelheim to delay the litigation and media attention and force them to consider compensation for those affected.
The Bellwether cases represent a sampling of the cases currently pending, with two cases involving patient death from internal bleeding and two involving extended hospital stays for emergency bleeding.
DrugRisk previously reported that the FDA plans to open a new study of Pradaxa to determine if it is as safe as stalwart drug warfarin, after thousands of reports of patient injury or death from bleeding.
Pradaxa was launched in 2010 as a treatment for patients with atrial fibrillation to prevent blood clots and stroke. It was marketed as a safe and convenient alternative to warfarin, which has been used for decades. However, it was soon discovered that Pradaxa does not have an antidote to stop internal bleeding in emergencies like warfarin does.
So many lawsuits have been filed that a special Pradaxa multidistrict litigation court was created. Judge Herndon has already fined Boehringer almost $1 million for failing to turn over evidence about the drug’s development and marketing.
Last year, Boehringer Ingelheim earned over $1 billion from Pradaxa and sold the drug in more than 70 countries.
If you or a loved one suffered internal bleeding after taking Pradaxa, it is important to speak with a lawyer today about your rights to file a lawsuit. You may be entitled to substantial compensation. However, time is limited.
Due to the specialized nature of these cases, DrugRisk only recommends lawyers who have already handled Pradaxa lawsuits. Contact us today for more information on Pradaxa, or to speak with a lawyer.